المؤلفون: Hanna KS; Pharmacy, Mayo Clinic College of Medicine, Rochester, MN, USA., Campbell M; College of Pharmacy, University of Minnesota, MN, USA., Husak A; College of Pharmacy, University of Minnesota, MN, USA., Sturm S; College of Pharmacy, University of Minnesota, MN, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Jul; Vol. 26 (5), pp. 1190-1199. Date of Electronic Publication: 2020 Apr 11.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Lymphoma, Mantle-Cell/*drug therapy , Protein Kinase Inhibitors/*therapeutic use, Adenine/analogs & derivatives ; Agammaglobulinaemia Tyrosine Kinase/antagonists & inhibitors ; Benzamides/administration & dosage ; Humans ; Immunotherapy ; Piperidines/administration & dosage ; Pyrazines/administration & dosage ; Pyrazoles/administration & dosage ; Pyrimidines/administration & dosage

المؤلفون: Ghasoub R; National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar., Albattah A; National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar., Elazzazy S; National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar., Alokka R; National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar., Nemir A; College of Pharmacy, Qatar University, Doha, Qatar., Alhijji I; National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar., Taha R; National Center for Cancer Care and Research, Hamad Medical Corporation (HMC), Doha, Qatar.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Mar; Vol. 26 (2), pp. 487-491. Date of Electronic Publication: 2019 Jun 19.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Agammaglobulinaemia Tyrosine Kinase/*antagonists & inhibitors , Cellulitis/*chemically induced , Ecthyma/*chemically induced , Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy , Neoplasm Recurrence, Local/*drug therapy , Pyrazoles/*adverse effects , Pyrimidines/*adverse effects, Adenine/analogs & derivatives ; Aged ; Cellulitis/diagnosis ; Ecthyma/diagnosis ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Male ; Neoplasm Recurrence, Local/diagnosis ; Piperidines ; Protein Kinase Inhibitors/therapeutic use ; Skin/drug effects ; Skin/pathology

المؤلفون: Gülsaran SK; Faculty of Medicine, Department of Hematology, Edirne, Turkey., Baysal M; Faculty of Medicine, Department of Hematology, Edirne, Turkey., Demirci U; Faculty of Medicine, Department of Hematology, Edirne, Turkey., Baş V; Faculty of Medicine, Department of Hematology, Edirne, Turkey., Kirkizlar HO; Faculty of Medicine, Department of Hematology, Edirne, Turkey., Umit E; Faculty of Medicine, Department of Hematology, Edirne, Turkey., Demir AM; Faculty of Medicine, Department of Hematology, Edirne, Turkey.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Mar; Vol. 26 (2), pp. 478-480. Date of Electronic Publication: 2019 May 29.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Agammaglobulinaemia Tyrosine Kinase/*antagonists & inhibitors , Cardiomyopathies/*chemically induced , Late Onset Disorders/*chemically induced , Pyrazoles/*adverse effects , Pyrimidines/*adverse effects , Ventricular Dysfunction, Left/*chemically induced, Adenine/analogs & derivatives ; Aged ; Cardiomyopathies/diagnosis ; Female ; Humans ; Late Onset Disorders/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Piperidines ; Protein Kinase Inhibitors/adverse effects ; Protein Kinase Inhibitors/therapeutic use ; Pyrazoles/therapeutic use ; Pyrimidines/therapeutic use ; Ventricular Dysfunction, Left/diagnosis

المؤلفون: Hanna KS; Mayo Clinic College of Medicine, Mayo Clinic & University of Minnesota Medical Center, Rochester, MN, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Jan; Vol. 26 (1), pp. 146-155. Date of Electronic Publication: 2019 Jun 12.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Disease Management*, Antineoplastic Agents/*therapeutic use , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Immunotherapy/*trends , Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy, Adenine/analogs & derivatives ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Humans ; Immunotherapy/methods ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Piperidines ; Pyrazoles/therapeutic use ; Pyrimidines/therapeutic use ; Sulfonamides/therapeutic use

المؤلفون: Hartsell L; 1 Wingate University School of Pharmacy, Wingate, NC, USA., Janes A; 2 Department of Oncology, Carolinas Healthcare System NorthEast, Levine Cancer Institute, Concord, NC, USA., Larck C; 2 Department of Oncology, Carolinas Healthcare System NorthEast, Levine Cancer Institute, Concord, NC, USA., Park S; 2 Department of Oncology, Carolinas Healthcare System NorthEast, Levine Cancer Institute, Concord, NC, USA., Arnall JR; 2 Department of Oncology, Carolinas Healthcare System NorthEast, Levine Cancer Institute, Concord, NC, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2019 Sep; Vol. 25 (6), pp. 1534-1539. Date of Electronic Publication: 2019 Feb 13.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Brain Diseases/*drug therapy , Protein Kinase Inhibitors/*therapeutic use , Pyrazoles/*therapeutic use , Pyrimidines/*therapeutic use , Waldenstrom Macroglobulinemia/*drug therapy, Adenine/analogs & derivatives ; Brain Diseases/diagnostic imaging ; Brain Diseases/etiology ; Humans ; Male ; Middle Aged ; Piperidines ; Syndrome ; Treatment Outcome ; Waldenstrom Macroglobulinemia/complications ; Waldenstrom Macroglobulinemia/diagnostic imaging

المؤلفون: Faisal MS; 1 Department of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, USA., Shaikh H; 1 Department of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, USA., Khattab A; 1 Department of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, USA., Albrethsen M; 2 Department of Hematology-Oncology, Allegheny Health Network, Pittsburgh, PA, USA., Fazal S; 2 Department of Hematology-Oncology, Allegheny Health Network, Pittsburgh, PA, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2019 Sep; Vol. 25 (6), pp. 1486-1490. Date of Electronic Publication: 2018 Jul 25.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Aspergillus fumigatus*/drug effects , Aspergillus fumigatus*/isolation & purification, Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy , Neuroaspergillosis/*chemically induced , Protein Kinase Inhibitors/*adverse effects , Pyrazoles/*adverse effects , Pyrimidines/*adverse effects, Adenine/analogs & derivatives ; Aged ; Antifungal Agents/administration & dosage ; B-Lymphocytes/drug effects ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnostic imaging ; Male ; Neuroaspergillosis/diagnostic imaging ; Neuroaspergillosis/drug therapy ; Piperidines

المؤلفون: McFarland AJ; School of Pharmacy, Gold Coast Campus, Griffith University, Queensland 4222, Australia., Grant GD, Perkins AV, Flegg C, Davey AK, Allsopp TJ, Renshaw G, Kavanagh J, McDermott CM, Anoopkumar-Dukie S

المصدر: International journal of toxicology [Int J Toxicol] 2013 May-Jun; Vol. 32 (3), pp. 209-18. Date of Electronic Publication: 2013 Mar 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Adenine/*analogs & derivatives , Astrocytoma/*metabolism , Neuroblastoma/*metabolism , Pyocyanine/*toxicity, Adenine/administration & dosage ; Adenine/pharmacology ; Autophagy/physiology ; Caspase 3/genetics ; Caspase 3/metabolism ; Cell Line, Tumor ; Dinoprostone/genetics ; Dinoprostone/metabolism ; Drug Therapy, Combination ; Gene Expression Regulation/drug effects ; Humans ; Interleukin-8/genetics ; Interleukin-8/metabolism ; Leukotriene B4/genetics ; Leukotriene B4/metabolism ; Staining and Labeling

المؤلفون: Vourvahis M; Pfizer Global Research and Development, New York, NY, USA. manoli.vourvahis@pfizer.com., Davis J, Langdon G, Layton G, Fang J, Choo HW, Hansson AG, Tawadrous M

المصدر: Antiviral therapy [Antivir Ther] 2013; Vol. 18 (6), pp. 745-54. Date of Electronic Publication: 2013 Apr 04.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE

مواضيع طبية MeSH: Adenine/*analogs & derivatives , Anti-HIV Agents/*pharmacokinetics , Deoxycytidine/*analogs & derivatives , Dideoxynucleosides/*pharmacokinetics , Lamivudine/*pharmacokinetics , Nitriles/*pharmacokinetics , Organophosphonates/*pharmacokinetics , Pyrazoles/*pharmacokinetics , Zidovudine/*pharmacokinetics, Adenine/administration & dosage ; Adenine/adverse effects ; Adenine/pharmacokinetics ; Adult ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Deoxycytidine/pharmacokinetics ; Dideoxynucleosides/administration & dosage ; Dideoxynucleosides/adverse effects ; Drug Combinations ; Drug Interactions ; Emtricitabine ; Female ; HIV Infections/drug therapy ; HIV Infections/virology ; Healthy Volunteers ; Humans ; Lamivudine/administration & dosage ; Lamivudine/adverse effects ; Male ; Middle Aged ; Nitriles/administration & dosage ; Nitriles/adverse effects ; Organophosphonates/administration & dosage ; Organophosphonates/adverse effects ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Tenofovir ; Young Adult ; Zidovudine/administration & dosage ; Zidovudine/adverse effects

المؤلفون: Gracey DM; Renal Unit, Royal Prince Alfred Hospital, Sydney, Australia. david.gracey@sswahs.nsw.gov.au., Snelling P, McKenzie P, Strasser SI

المصدر: Antiviral therapy [Antivir Ther] 2013; Vol. 18 (7), pp. 945-8. Date of Electronic Publication: 2013 Jul 10.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE

مواضيع طبية MeSH: Adenine/*analogs & derivatives , Antiviral Agents/*adverse effects , Fanconi Syndrome/*chemically induced , Hepatitis B, Chronic/*complications , Organophosphonates/*adverse effects , Reverse Transcriptase Inhibitors/*adverse effects, Adenine/adverse effects ; Adenine/therapeutic use ; Adult ; Antiviral Agents/therapeutic use ; Biopsy ; Creatinine/blood ; Fanconi Syndrome/diagnosis ; Hepatitis B, Chronic/drug therapy ; Humans ; Kidney/drug effects ; Kidney/pathology ; Kidney/physiopathology ; Kidney/ultrastructure ; Male ; Middle Aged ; Organophosphonates/therapeutic use ; Phosphates/blood ; Reverse Transcriptase Inhibitors/therapeutic use ; Tenofovir

المؤلفون: Karatayli E; Ankara University, Institute of Hepatology, Ankara, Turkey., Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C

المصدر: Antiviral therapy [Antivir Ther] 2013; Vol. 18 (1), pp. 77-85. Date of Electronic Publication: 2012 Aug 10.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE

مواضيع طبية MeSH: Adenine/*analogs & derivatives , Antiviral Agents/*pharmacology , Drug Resistance, Viral/*genetics , Guanine/*analogs & derivatives , Hepatitis B virus/*drug effects , Hepatitis B virus/*genetics , Hepatitis B, Chronic/*drug therapy , Organophosphonates/*therapeutic use, Adenine/pharmacology ; Adenine/therapeutic use ; Adult ; Antiviral Agents/therapeutic use ; Drug Resistance, Viral/drug effects ; Drug Therapy, Combination ; Female ; Genome, Viral/drug effects ; Genome, Viral/genetics ; Guanine/pharmacology ; Guanine/therapeutic use ; Hepatitis B virus/classification ; Hepatitis B, Chronic/virology ; Humans ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Mutation ; Organophosphonates/pharmacology ; Tenofovir ; Treatment Outcome ; Young Adult